News | Cath Lab

May 13, 2016 — In the largest study of its kind, a new device has been found to significantly reduce the volume of ...

Home May 13, 2016
Home
News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes LLC is enhancing its production operations at the University of Missouri Research Reactor (MURR) in Columbia, Mo.

Home May 13, 2016
Home
Case Study | Analytics Software

The hospitals of UnityPoint Health – Des Moines operate under a shared vision “Best outcome for every patient, every ...

Home May 13, 2016
Home
Videos | HIMSS

ITN/DAIC Editor Dave Fornell takes a tour of some of the most innovative new healthcare technology trends in health ...

Home May 13, 2016
Home
Technology | Wearables

May 12, 2016 — CareTaker Medical announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance ...

Home May 12, 2016
Home
News | Intravascular Imaging

May 12, 2016 — Collaboration between two National Institute of Biomedical Imaging and Bioengineering (NIBIB)-funded labs ...

Home May 12, 2016
Home
Radiation dose management, radiation dose monitoring, X-ray dose
Feature | Radiation Dose Management | Lori Webb, R.T. (R) and Tom Watson, RCVT

Healthcare organizations, clinicians and medical equipment manufacturers have long focused on the management and ...

Home May 12, 2016
Home
News

Patients with Wolff-Parkinson-White syndrome who receive catheter ablation to cure their abnormal heart rhythms are just as likely as non-ablated patients to develop atrial fibrillation no matter what age they receive ablation, according to a new study.

Home May 11, 2016
Home
GE Healthcare's cardiac ultrasound strain assessment software helps quantify left ventricular wall motion to determine if there is damage to cardiac function due to cancer therapy. GE Ultrasound, GE echo, strain, cardio-oncology
Feature | Cardio-oncology | Dave Fornell

Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat cancer patients for the second leading cause of death among cancer survivors — cardiovascular disease brought on by their treatments. Specific types of chemotherapy and chest-directed radiation therapy are known to cause cardiac dysfunction, mainly due to cardiotoxicity — the symptoms of which may not present until months or even years after cancer treatment.

Home May 11, 2016
Home
Technology | Cardiac Resynchronization Therapy Devices (CRT)

Medtronic plc recently announced it received U.S. Food and Drug Administration (FDA) approval for the first and only magnetic resonance imaging (MRI)-conditional cardiac resynchronization therapy defibrillators (CRT-Ds) for the treatment of heart failure.

Home May 11, 2016
Home
News

Imricor Medical Systems announced enrollment of the first patients in a clinical study to evaluate the Vision-MR Ablation Catheter for the treatment of atrial flutter under real-time magnetic resonance imaging (MRI) guidance.

Home May 10, 2016
Home
News | Magnetic Resonance Imaging (MRI)

May 10, 2016 — Cardiovascular magnetic resonance (CMR) is a stronger predictor of risk for major adverse cardiovascular ...

Home May 10, 2016
Home
News | Pacemakers

Medtronic plc announced clinical results highlighting the strong safety and performance profile of the miniaturized Micra Transcatheter Pacing System (TPS) at Heart Rhythm 2016, the Heart Rhythm Society's 37th Annual Scientific Sessions, May 4-7 in San Francisco.

Home May 10, 2016
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

The first-ever trial using new SonR hemodynamic sensor technology proves to be safely and effectively applied in cardiac resynchronization therapy (CRT) patients.

Home May 10, 2016
Home
News | Pacemakers

Results from a first-of-its-kind study identify a significant increase in the incidence of atrial fibrillation (AF) among patients with pacemaker-detected sleep apnea.

Home May 09, 2016
Home
Subscribe Now